“EVALUATING THE IMPACT OF MODERN ANTI-DIABETIC DRUGS ON SURVIVAL OUTCOMES IN LUNG CANCER PATIENTS WITH TYPE 2 DIABETES” (2025) Journal of Medical & Health Sciences Review, 2(3). doi:10.62019/hmpfcj11.